Jesse Nussbaum
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 23, 2024
Single- and Multiple-Dose Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist, in Healthy Adults.Jesse C Nussbaum, Azher Hussain, Peter Butera
|Jun 13, 2023
Considerations for Cell and Gene Therapy Programs Entering the Clinical Space.Geoffrey A Walford, An Bautmans, Carol Cannon
|Jun 07, 2022
A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older Adults.Jesse Nussbaum, Azher Hussain, Anthony Ford
|Jun 03, 2022
Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist.Jesse C Nussbaum, Azher Hussain, K Chris Min
|Feb 02, 2022
Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans.Jesse C Nussbaum, Azher Hussain, Bennett Ma
Pageof 1
![An Automated Radiosynthesis of [<sup>68</sup>Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=75)
